CL
TEVA icon

Choreo LLC’s Teva Pharmaceuticals TEVA Stock Holding History

Choreo LLC’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Buy
35,789
+727
+2% +$24.2K 0.01% 576
2026
Q1 		$1.06M Buy
35,062
+25,122
+253% +$808K 0.01% 599
2025
Q4 		$312K Buy
+9,940
New +$245K ﹤0.01% 1195
2024
Q4 		– Sell
-10,593
Closed -$187K – 1730
2024
Q3 		$187K Buy
+10,593
New +$185K ﹤0.01% 1480
2017
Q3 		– Sell
-8,485
Closed -$282K – 278
2017
Q2 		$282K Buy
+8,485
New +$263K 0.04% 218

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Choreo LLC's TEVA Position: Q2 2026 in Review

Choreo LLC increased its Teva Pharmaceuticals (TEVA) stake by 2.1% in Q2 2026, buying an estimated $24.2K and bringing the position to 35,789 shares worth $1.21M. The position accounts for 0.01% of the portfolio, ranked #576.

Choreo LLC first reported a position in TEVA in Q2 2017 and has held it in 5 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Choreo LLC held 35,789 shares of Teva Pharmaceuticals worth $1.21M as of Q2 2026.
  • Choreo LLC bought 727 Teva Pharmaceuticals shares in Q2 2026, an estimated $24.2K.
  • Teva Pharmaceuticals made up 0.01% of Choreo LLC's portfolio in Q2 2026, its #576 holding.
  • Choreo LLC first reported a position in Teva Pharmaceuticals in Q2 2017 and has held it in 5 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.